BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10558427)

  • 1. Taking behavioralism seriously: some evidence of market manipulation.
    Hanson JD; Kysar DA
    Harv Law Rev; 1999 May; 112(7):1420-572. PubMed ID: 10558427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Big pharma and health care: unsolvable conflict of interests between private enterprise and public health.
    Brezis M
    Isr J Psychiatry Relat Sci; 2008; 45(2):83-9; discussion 90-4. PubMed ID: 18982834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications.
    Pederson LL; Nelson DE
    Nicotine Tob Res; 2007 May; 9(5):525-34. PubMed ID: 17454709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes.
    Dunsby J; Bero L
    Tob Control; 2004 Dec; 13(4):362-9. PubMed ID: 15564619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking in Malaysia: promotion and control.
    Soon Kee Teoh
    World Smoking Health; 1984; 9(2):27-30. PubMed ID: 12179603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco industry tactics for resisting public policy on health.
    Saloojee Y; Dagli E
    Bull World Health Organ; 2000; 78(7):902-10. PubMed ID: 10994263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Morgan S; Mintzes B; Barer M
    J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huckstering health.
    Aufderheide P
    Channels; 1985; 5(1):51-2. PubMed ID: 12267261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical advertising as a consumer empowerment device.
    Rubin PH
    J Biolaw Bus; 2001; 4(4):59-65. PubMed ID: 12751498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing market share through consumer marketing: a case study in obstetrics.
    Kingsley VH
    Health Care Strateg Manage; 1986 May; 4(5):16-20. PubMed ID: 10277074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How consumers evaluate health care quality: Part II.
    Moore ST; Bopp KD
    Health Mark Q; 1999; 17(1):1-8. PubMed ID: 11066719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the tobacco use epidemic IV. The vector: Tobacco industry data sources and recommendations for research and evaluation.
    Cruz TB
    Prev Med; 2009 Jan; 48(1 Suppl):S24-34. PubMed ID: 18976685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are marketing campaigns in Taiwan by foreign tobacco companies targeting young smokers?
    Wen CP; Chen T; Tsai YY; Tsai SP; Chung WS; Cheng TY; Levy DT; Hsu CC; Peterson R; Liu WY
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i38-44. PubMed ID: 15923447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco industry marketing, population-based tobacco control, and smoking behavior.
    Pierce JP
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S327-34. PubMed ID: 18021907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of direct-to-consumer advertising of prescription drugs.
    Calfee JE
    Clin Pharmacol Ther; 2007 Oct; 82(4):357-60. PubMed ID: 17851572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The issue of applying marketing on the pharmaceutical market in Serbia.
    Dickov V; Dickov A; Martinović-Mitrović S
    Eur Rev Med Pharmacol Sci; 2011 Mar; 15(3):275-83. PubMed ID: 21528773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.